About US
Contact us
>>Back
RegeneRx Awarded NIH Grant to Develop Cardiac Drug
- Publisher：
- Publication：2010/5/20
RegeneRx Biopharmaceuticals has been awarded a $3m grant from the National Institute of Health's National Heart, Lung and Blood Institute for a heart attack drug.
The grant is to accelerate clinical development of RGN-352, a peptide-based drug candidate to treat patients with heart problems.
The grant has been provided under the American Reinvestment and Recovery Act of 2009 to facilitate research and commercial development of the drug.
RegeneRx plans to initiate the Phase II clinical trial later this year.
Source: web of pharmaceutical-technology